From: Post-mortem examination of high mortality in patients with heart failure and atrial fibrillation
Mode of death | Post-mortem performed (n = 186) | Post-mortem not performed (n = 105) |
---|---|---|
HF-related death | Deaths = 92 (49.5%) | Deaths = 44 (41.9%) |
Dilated cardiomyopathy (n = 35) | Dilated cardiomyopathy (n = 17) | |
Multi-organ congestion on post-mortem (n = 14) | Valvular heart disease (n = 7) | |
Valvular heart disease (n = 12) | Hypertensive cardiomyopathy (n = 5) | |
Myo-pericardial disease (n = 11) | Myo-pericardial disease (n = 4) | |
Cardiac dystrophy due to brown atrophy (n = 9) | Hypertrophic cardiomyopathy (n = 2) | |
Restrictive cardiomyopathy (n = 2) | Endocrine-related cardiomyopathy (n = 2) | |
Hypertensive cardiomyopathy (n = 4) | Cardiomyopathy with an underlying systemic autoimmune condition (n = 2) | |
Hypertrophic cardiomyopathy (n = 3) | Cardiomyopathy related to cancer treatment (n = 2) | |
Cardiomyopathy with an underlying systemic autoimmune condition (n = 1) | Cardiomyopathy related to neuromuscular conditions (n = 1) | |
Cardiomyopathy related to neuromuscular conditions (n = 1) | Restrictive cardiomyopathy (n = 1) | |
 | Tako-Tsubo cardiomyopathy (n = 1) | |
Vascular death | Deaths = 41 (22.0%) | Deaths = 34 (32.4%) |
Myocardial infarction (n = 13) | Stroke (n = 16) | |
Non-coronary/non-cerebral atherosclerosis (n = 11) | Non-coronary/non-cerebral atherosclerosis (n = 7) | |
Stroke (n = 11) | Pulmonary embolism (n = 6) | |
Pulmonary embolism (n = 4) | Myocardial infarction (n = 5) | |
Aortic dissection (n = 2) |  | |
Non-CV death | Deaths = 53 (28.5%) | Deaths = 27 (25.7%) |
Malignancies (n = 19) | Kidney failure (n = 10) | |
Haemorrhage (n = 6) | Decompensated diabetes (n = 9) | |
Pneumonia (n = 5) | Malignancies (n = 7) | |
Kidney failure (n = 5) | Pneumonia (n = 1) | |
Decompensated diabetes (n = 5) |  | |
Hypovolemic shock (n = 4)a |  | |
Endocarditis (n = 3) |  | |
Bronchopneumonia (n = 3) |  | |
COPD (n = 2) |  | |
Sepsis (n = 1) |  |